Skip to main content
. 2022 Jun 16;11(6):1183. doi: 10.3390/antiox11061183

Figure 2.

Figure 2

Cell viability of HaCaT keratinocytes treated with morin. Data were from triplicate experiments and presented as mean ± SD. * indicates a statistically significant difference with control, p < 0.05.